Cancer pharmacology is the research on how cancer drugs work with cancer cells to effectively treat and control tumors. The session "Cancer Pharmacology" emphasizes the recent breakthroughs in drug mechanisms, optimizing treatment strategies, and designing new treatments for different cancers.
This domain encompasses a broad array of treatments, such as chemotherapy, targeted treatments, immunotherapy, hormone therapy, and combination therapy. Knowing how these drugs function at the cellular and molecular level allows clinicians to choose the most optimal treatments with the least side effects. Scientists also investigate mechanisms of drug resistance, which may constrain the effectiveness of therapy, and devise ways to counteract them.
The session discusses individualized medicine strategies, wherein pharmacologic interventions are designed on the basis of tumor genetics, biomarkers, and patient variables. Pharmacokinetics, pharmacodynamics, and drug delivery systems have been improved, and they are making cancer therapies more precise and effective.
Participants will receive insights into new drug therapies, new treatments, and novel modalities in cancer pharmacology. This session highlights the necessity of marrying pharmacological science with clinical practice to enhance patient results, maximize therapy, and propel the development of future cancer therapies."
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
